Sigyn Therapeutics, Inc. (SIGY) › Total LiabilitiesSigyn Therapeutics, Inc. (SIGY) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $462.8K2015: $1.51M2017: $4.16M2018: $4.58M2019: $9102020: $594.9K2021: $974.8K2022: $2.24M2023: $3.73M2024: $4.67M$4.67M2014Total Liabilities (USD)2024Fiscal YearTotal LiabilitiesChange YoY2024$4.67M+25.1%2023$3.73M+67.0%2022$2.24M+129.4%2021$974.8K+63.9%2020$594.9K+65274.0%2019$910-100.0%2018$4.58M+9.9%2017$4.16M—2015$1.51M+226.0%2014$462.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share